| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.932 | 0.001 | 0.932 | Carbonic anhydrase XV inhibitor | 0.257 0.011 CID_118753620 | ||
| 0.886 | 0.003 | 0.98 | Non-steroidal antiinflammatory agent | 0.98 0.002 CID_118753620 | CID_118753620 | |
| 0.807 | 0.002 | 0.807 | Carbonic anhydrase VI inhibitor | 0.474 0.003 CID_118753620 | ||
| 0.766 | 0.003 | 0.766 | Cyclooxygenase inhibitor | 0.608 0.004 CID_118753620 | ||
| 0.758 | 0.002 | 0.758 | Carbonic anhydrase III inhibitor | 0.478 0.003 CID_118753620 | ||
| 0.727 | 0.004 | 0.727 | Cyclooxygenase 1 inhibitor | 0.577 0.004 CID_118753620 | ||
| 0.722 | 0.003 | 0.722 | Cyclooxygenase 2 inhibitor | 0.544 0.004 CID_118753620 | ||
| 0.66 | 0.003 | 0.66 | Carbonic anhydrase XIII inhibitor | 0.395 0.004 CID_118753620 | ||
| 0.611 | 0.05 | 0.818 | Antiinflammatory | 0.818 0.013 CID_118753620 | CID_118753620 | |
| 0.548 | 0.005 | 0.548 | Diuretic | 0.5 0.008 CID_118753620 | ||
| 0.537 | 0.003 | 0.568 | Carbonic anhydrase inhibitor | 0.568 0.003 CID_118753620 | CID_118753620 | |
| 0.526 | 0.003 | 0.555 | Carbonic anhydrase IX inhibitor | 0.555 0.003 CID_118753620 | CID_118753620 | |
| 0.479 | 0.003 | 0.57 | Carbonic anhydrase XII inhibitor | 0.57 0.003 CID_118753620 | CID_118753620 | |
| 0.462 | 0.002 | 0.462 | Carbonic anhydrase VB inhibitor | 0.077 0.024 CID_118753620 | ||
| 0.413 | 0.003 | 0.413 | Carbonic anhydrase I inhibitor | 0.329 0.004 CID_118753620 | ||
| 0.412 | 0.003 | 0.412 | Electrolyte absorption antagonist | |||
| 0.397 | 0.005 | 0.397 | Alkaline phosphatase inhibitor | 0.36 0.007 CID_118753620 | ||
| 0.394 | 0.003 | 0.394 | Carbonic anhydrase V inhibitor | 0.091 0.03 CID_118753620 | ||
| 0.378 | 0.003 | 0.378 | Carbonic anhydrase II inhibitor | 0.335 0.004 CID_118753620 | ||
| 0.406 | 0.036 | 0.406 | Lipoxygenase inhibitor | |||
| 0.369 | 0.003 | 0.369 | Carbonic anhydrase VA inhibitor | 0.101 0.024 CID_118753620 | ||
| 0.429 | 0.073 | 0.429 | Analgesic | 0.257 0.177 CID_118753620 | ||
| 0.323 | 0.003 | 0.424 | Carbonic anhydrase XIV inhibitor | 0.424 0.003 CID_118753620 | CID_118753620 | |
| 0.325 | 0.006 | 0.325 | Cyclin-dependent kinase 3 inhibitor | 0.215 0.026 CID_118753620 | ||
| 0.361 | 0.056 | 0.469 | Caspase 3 stimulant | 0.469 0.025 CID_118753620 | CID_118753620 | |
| 0.326 | 0.042 | 0.326 | Transcription factor STAT3 inhibitor | 0.2 0.133 CID_118753620 | ||
| 0.288 | 0.009 | 0.288 | Sodium channel (voltage-gated) blocker | |||
| 0.264 | 0.005 | 0.264 | Interleukin 2 antagonist | 0.168 0.012 CID_118753620 | ||
| 0.241 | 0.005 | 0.241 | Interleukin 5 antagonist | 0.158 0.009 CID_118753620 | ||
| 0.249 | 0.013 | 0.249 | Interleukin 4 antagonist | 0.225 0.017 CID_118753620 | ||
| 0.289 | 0.063 | 0.289 | Transcription factor STAT inhibitor | |||
| 0.228 | 0.004 | 0.228 | Carbonic anhydrase VII inhibitor | 0.052 0.025 CID_118753620 | ||
| 0.301 | 0.078 | 0.301 | Sodium/bile acid cotransporter inhibitor | 0.197 0.192 CID_118753620 | ||
| 0.285 | 0.071 | 0.285 | Aldehyde oxidase inhibitor | |||
| 0.306 | 0.106 | 0.306 | Toll-Like receptor 7 agonist | |||
| 0.22 | 0.021 | 0.22 | 5-Lipoxygenase inhibitor | |||
| 0.223 | 0.025 | 0.223 | Sodium channel blocker | |||
| 0.201 | 0.014 | 0.201 | Potassium channel (Ca-activated) activator | |||
| 0.187 | 0.009 | 0.187 | Heat shock protein 70 antagonist | 0.153 0.039 CID_118753620 | ||
| 0.292 | 0.116 | 0.292 | Toll-Like receptor agonist | |||
| 0.179 | 0.014 | 0.179 | Creatine kinase inhibitor | |||
| 0.213 | 0.051 | 0.213 | Histone acetyltransferase inhibitor | |||
| 0.17 | 0.009 | 0.17 | Prostaglandin-E synthase inhibitor | |||
| 0.212 | 0.055 | 0.212 | Dual specificity phosphatase 3 inhibitor | |||
| 0.163 | 0.008 | 0.18 | Factor Xa inhibitor | 0.18 0.007 CID_118753620 | CID_118753620 | |
| 0.148 | 0.004 | 0.148 | Carbonic anhydrase IV inhibitor | 0.04 0.033 CID_118753620 | ||
| 0.155 | 0.013 | 0.155 | Nav1.8 sodium channel blocker | |||
| 0.194 | 0.055 | 0.301 | Anticoagulant | 0.301 0.028 CID_118753620 | CID_118753620 | |
| 0.215 | 0.091 | 0.215 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.164 | 0.041 | 0.164 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.163 | 0.04 | 0.163 | MAP kinase kinase 4 inhibitor | |||
| 0.129 | 0.008 | 0.129 | Factor X inhibitor | 0.059 0.018 CID_118753620 | ||
| 0.132 | 0.014 | 0.132 | Nav1.7 sodium channel blocker | |||
| 0.201 | 0.087 | 0.201 | EphB2 antagonist | |||
| 0.126 | 0.024 | 0.126 | I kappa B kinase inhibitor | |||
| 0.134 | 0.034 | 0.134 | Ca(v)2.2 blocker | |||
| 0.164 | 0.064 | 0.165 | Hexokinase inhibitor | 0.165 0.063 CID_118753620 | CID_118753620 | |
| 0.173 | 0.079 | 0.173 | Amyloid beta precursor protein antagonist | |||
| 0.127 | 0.034 | 0.127 | Uric acid excretion stimulant | 0.121 0.037 CID_118753620 | ||
| 0.168 | 0.076 | 0.168 | Dual specificity phosphatase inhibitor | |||
| 0.097 | 0.008 | 0.097 | Aldosterone antagonist | |||
| 0.091 | 0.005 | 0.091 | Purinergic P2X4 antagonist | |||
| 0.084 | 0.005 | 0.084 | Glutamate (mGluR3) antagonist | |||
| 0.092 | 0.016 | 0.092 | I kappa B kinase 2 inhibitor | |||
| 0.159 | 0.084 | 0.159 | Antipruritic | |||
| 0.172 | 0.097 | 0.172 | Focal adhesion kinase 2 inhibitor | |||
| 0.079 | 0.004 | 0.079 | Liver X receptor beta antagonist | |||
| 0.123 | 0.051 | 0.123 | CDK3/cyclin E inhibitor | |||
| 0.149 | 0.078 | 0.149 | CF transmembrane conductance regulator agonist | 0.148 0.08 CID_118753620 | ||
| 0.113 | 0.043 | 0.113 | Phosphodiesterase 7B inhibitor | |||
| 0.114 | 0.045 | 0.114 | Factor V inhibitor | |||
| 0.132 | 0.064 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.035 CID_118753620 | CID_118753620 | |
| 0.085 | 0.018 | 0.096 | Nitric oxide donor | 0.096 0.011 CID_118753620 | CID_118753620 | |
| 0.17 | 0.104 | 0.17 | Interleukin antagonist | |||
| 0.14 | 0.074 | 0.14 | Mannose-6-phosphate isomerase inhibitor | 0.134 0.08 CID_118753620 | ||
| 0.092 | 0.03 | 0.092 | Epoxide hydrolase inhibitor | |||
| 0.091 | 0.029 | 0.091 | Phosphodiesterase 4B inhibitor | |||
| 0.07 | 0.01 | 0.07 | Urate transporter 1 inhibitor | |||
| 0.063 | 0.005 | 0.063 | AMPA receptor agonist | 0.038 0.02 CID_118753620 | ||
| 0.155 | 0.098 | 0.155 | Lipocortins synthesis antagonist | |||
| 0.07 | 0.014 | 0.07 | Mineralocorticoid receptor antagonist | |||
| 0.063 | 0.008 | 0.063 | Liver X receptor beta agonist | |||
| 0.088 | 0.033 | 0.088 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.092 | 0.04 | 0.092 | Phosphodiesterase 3A inhibitor | |||
| 0.073 | 0.022 | 0.073 | Prostaglandin E2 antagonist | |||
| 0.136 | 0.086 | 0.335 | Hemostatic | 0.335 0.013 CID_118753620 | CID_118753620 | |
| 0.1 | 0.051 | 0.148 | Phosphodiesterase 6D inhibitor | 0.148 0.01 CID_118753620 | CID_118753620 | |
| 0.121 | 0.074 | 0.121 | Cathepsin H inhibitor | |||
| 0.065 | 0.022 | 0.065 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.126 | 0.083 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.055 | 0.013 | 0.055 | Glutamate (mGluR group II) antagonist | |||
| 0.14 | 0.1 | 0.14 | Mcl-1 antagonist | |||
| 0.226 | 0.186 | 0.226 | 15-Lipoxygenase inhibitor | |||
| 0.113 | 0.073 | 0.113 | Calcium channel N-type blocker | |||
| 0.049 | 0.01 | 0.049 | Liver X receptor antagonist | |||
| 0.075 | 0.039 | 0.075 | Potassium channel large-conductance Ca-activated activator | |||
| 0.096 | 0.061 | 0.096 | CDK2/cyclin A inhibitor | |||
| 0.04 | 0.008 | 0.04 | Prostaglandin EP1 antagonist | |||
| 0.065 | 0.034 | 0.065 | Cyclin H inhibitor | |||
| 0.051 | 0.022 | 0.051 | Liver X receptor agonist | |||
| 0.108 | 0.079 | 0.108 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.03 | 0.004 | 0.03 | Carbonic anhydrase VIII inhibitor | |||
| 0.03 | 0.004 | 0.03 | Carbonic anhydrase X inhibitor | |||
| 0.055 | 0.03 | 0.055 | Carbonic anhydrase II stimulant | |||
| 0.133 | 0.109 | 0.133 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.1 | 0.077 | 0.1 | Protein kinase (CK2) alpha inhibitor | |||
| 0.035 | 0.012 | 0.035 | Liver X receptor alpha antagonist | |||
| 0.234 | 0.213 | 0.234 | MAP kinase kinase 6 inhibitor | |||
| 0.08 | 0.059 | 0.08 | Ca(v)3.1 blocker | |||
| 0.086 | 0.066 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.035 | 0.015 | 0.035 | Glutamate (mGluR2) antagonist | |||
| 0.042 | 0.024 | 0.042 | Dihydropteroate synthase inhibitor | |||
| 0.087 | 0.07 | 0.087 | ABCA1 expression enhancer | |||
| 0.02 | 0.004 | 0.02 | Carbonic anhydrase XI inhibitor | |||
| 0.093 | 0.078 | 0.093 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.093 | 0.079 | 0.093 | Ferrochelatase inhibitor | |||
| 0.088 | 0.075 | 0.088 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.14 | 0.13 | 0.14 | Neurotensin receptor agonist | |||
| 0.037 | 0.028 | 0.037 | TRPM8 blocker | |||
| 0.038 | 0.03 | 0.038 | Retinoic acid alpha receptor agonist | |||
| 0.165 | 0.157 | 0.333 | Peptidyltransferase inhibitor | 0.333 0.015 CID_118753620 | CID_118753620 | |
| 0.088 | 0.08 | 0.088 | Urease inhibitor | |||
| 0.042 | 0.034 | 0.042 | Guanylate cyclase stimulant | |||
| 0.042 | 0.034 | 0.042 | AICAR transformylase inhibitor | |||
| 0.059 | 0.052 | 0.059 | Trypsin inhibitor | |||
| 0.018 | 0.013 | 0.018 | Factor IX inhibitor | |||
| 0.058 | 0.053 | 0.058 | Heme oxygenase stimulant | |||
| 0.029 | 0.024 | 0.029 | Glucocorticoid antagonist | |||
| 0.028 | 0.024 | 0.028 | Purinergic P2Y14 antagonist | |||
| 0.05 | 0.048 | 0.05 | Potassium channel Kv1.5 blocker | |||
| 0.023 | 0.022 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.042 | 0.041 | 0.042 | AMPA receptor antagonist | |||
| 0.044 | 0.049 | 0.081 | Factor IXa inhibitor | 0.081 0.016 CID_118753620 | CID_118753620 | |
| 0.107 | 0.132 | 0.14 | Protein-tyrosine phosphatase inhibitor | 0.14 0.089 CID_118753620 | CID_118753620 | |
| 0.189 | 0.216 | 0.202 | Histamine release inhibitor | 0.202 0.2 CID_118753620 | CID_118753620 | |
| 0.075 | 0.122 | 0.224 | AMP-activated protein kinase stimulant | 0.224 0.008 CID_118753620 | CID_118753620 | |
| 0.18 | 0.233 | 0.227 | Antiobesity | 0.227 0.18 CID_118753620 | CID_118753620 | |
| 0.058 | 0.139 | 0.113 | Protein-tyrosine phosphatase 1B inhibitor | 0.113 0.068 CID_118753620 | CID_118753620 | |
| 0.06 | 0.143 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.059 CID_118753620 | CID_118753620 | |
| 0.138 | 0.241 | 0.521 | Transcription factor NF kappa B inhibitor | 0.521 0.041 CID_118753620 | CID_118753620 | |
| 0.146 | 0.257 | 0.518 | Antithrombotic | 0.518 0.027 CID_118753620 | CID_118753620 | |
| 0.106 | 0.222 | 0.18 | ATPase inhibitor | 0.18 0.058 CID_118753620 | CID_118753620 | |
| 0.098 | 0.225 | 0.236 | Platelet antagonist | 0.236 0.079 CID_118753620 | CID_118753620 | |
| 0.054 | 0.188 | 0.082 | Thioredoxin inhibitor | 0.082 0.077 CID_118753620 | CID_118753620 | |
| 0.054 | 0.197 | 0.223 | Amylase inhibitor | 0.223 0.036 CID_118753620 | CID_118753620 | |
| 0.133 | 0.329 | 0.498 | Antibacterial | 0.498 0.041 CID_118753620 | CID_118753620 | |
| 0.13 | 0.326 | 0.393 | Apoptosis antagonist | 0.393 0.04 CID_118753620 | CID_118753620 | |
| 0.071 | 0.278 | 0.179 | NOS3 expression enhancer | 0.179 0.05 CID_118753620 | CID_118753620 | |
| 0.061 | 0.271 | 0.148 | Cell wall synthesis inhibitor | 0.148 0.068 CID_118753620 | CID_118753620 | |
| 0.07 | 0.301 | 0.183 | Insulin secretagoues | 0.183 0.046 CID_118753620 | CID_118753620 | |
| 0.067 | 0.298 | 0.37 | Platelet adhesion inhibitor | 0.37 0.015 CID_118753620 | CID_118753620 | |
| 0.007 | 0.247 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.013 CID_118753620 | CID_118753620 | |
| 0.104 | 0.346 | 0.373 | Immunomodulator | 0.373 0.052 CID_118753620 | CID_118753620 | |
| 0.091 | 0.342 | 0.472 | Alpha-glucosidase inhibitor | 0.472 0.089 CID_118753620 | CID_118753620 | |
| 0.135 | 0.39 | 0.5 | Apoptosis agonist | 0.5 0.074 CID_118753620 | CID_118753620 | |
| 0.063 | 0.325 | 0.402 | Free radical scavenger | 0.402 0.028 CID_118753620 | CID_118753620 | |
| 0.04 | 0.343 | 0.141 | Toll-Like receptor 4 antagonist | 0.141 0.026 CID_118753620 | CID_118753620 | |
| 0.018 | 0.337 | 0.051 | Glucose-6-phosphate translocase inhibitor | 0.051 0.037 CID_118753620 | CID_118753620 | |
| 0.116 | 0.437 | 0.539 | Cyclophilin D inhibitor | 0.539 0.04 CID_118753620 | CID_118753620 | |
| 0.04 | 0.364 | 0.121 | Transcription factor NF kappa B stimulant | 0.121 0.025 CID_118753620 | CID_118753620 | |
| 0.055 | 0.388 | 0.351 | Tumour necrosis factor alpha release inhibitor | 0.351 0.038 CID_118753620 | CID_118753620 | |
| 0.027 | 0.392 | 0.112 | Beta glucuronidase inhibitor | 0.112 0.054 CID_118753620 | CID_118753620 | |
| 0.063 | 0.455 | 0.361 | Hypoglycemic | 0.361 0.035 CID_118753620 | CID_118753620 | |
| 0.025 | 0.423 | 0.171 | Thrombolytic | 0.171 0.067 CID_118753620 | CID_118753620 | |
| 0.008 | 0.415 | 0.234 | Selectin antagonist | 0.234 0.009 CID_118753620 | CID_118753620 | |
| 0.081 | 0.584 | 0.365 | Interleukin 2 agonist | 0.365 0.039 CID_118753620 | CID_118753620 | |
| 0.036 | 0.599 | 0.305 | Hepatoprotectant | 0.305 0.028 CID_118753620 | CID_118753620 | |
| 0.023 | 0.597 | 0.37 | Antioxidant | 0.37 0.041 CID_118753620 | CID_118753620 | |
| 0.03 | 0.647 | 0.312 | Immunosuppressant | 0.312 0.107 CID_118753620 | CID_118753620 | |
| 0.008 | 0.627 | 0.063 | Protein 50S ribosomal subunit inhibitor | 0.063 0.028 CID_118753620 | CID_118753620 | |
| 0.013 | 0.647 | 0.191 | Immunostimulant | 0.191 0.126 CID_118753620 | CID_118753620 | |
| 0.011 | 0.767 | 0.242 | Nitric oxide antagonist | 0.242 0.054 CID_118753620 | CID_118753620 | |
| 0.01 | 0.798 | 0.428 | Angiogenesis stimulant | 0.428 0.018 CID_118753620 | CID_118753620 | |
| 0.008 | 0.831 | 0.165 | Vasodilator | 0.165 0.137 CID_118753620 | CID_118753620 | |
| 0.006 | 0.869 | 0.048 | Antibiotic Aminoglycoside-like | 0.048 0.014 CID_118753620 | CID_118753620 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |